Science

Mar 25, 2025, 09:54

Myeloma Paper of the Day, March 25th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: CASSIOPEIA MRD data show dara maintenance improved MRD-negative rates vs. observation regardless of induction/consol. or risk status; D-VTd – dara produced highest landmark, accumulative and sustained MRD-negativity and PFS.”

“Daratumumab-Bortezomib-Thalidomide-Dexamethasone for Newly Diagnosed Myeloma: CASSIOPEIA Minimal Residual Disease Results”

Authors: Jill Corre, Laure Vincent, Philippe Moreau, Benjamin Hebraud, Cyrille Hulin, Fredrik Borgsten, Melissa Rowe, Robin Carson, Soraya Wuilleme, Pieter Sonneveld et al.

More posts featuring Robert Orlowski.

Benjamin Hebraud cancer CASSIOPEIA Cyrille Hulin Fredrik Borgsten Jill Corre Laure Vincent Melissa Rowe Myeloma Myeloma Paper of the Day OncoDaily Oncology Philippe Moreau Pieter Sonneveld Robert Orlowski Robin Carson Soraya Wuillème

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth